Restamin


Combined with:

Decadron

Indications and Reactions:

Role Indications Reactions
Secondary
Maternal Exposure During Pregnancy 35.1%
Premedication 9.9%
Drug Use For Unknown Indication 7.2%
Breast Cancer 6.3%
Breast Cancer Recurrent 5.4%
Chronic Hepatitis C 5.4%
Non-small Cell Lung Cancer 5.4%
Rheumatoid Arthritis 4.5%
Hypertension 3.6%
Medication Dilution 2.7%
Adverse Event 1.8%
Anaphylactic Reaction 1.8%
Antibiotic Prophylaxis 1.8%
Insomnia 1.8%
Metastatic Neoplasm 1.8%
Product Used For Unknown Indication 1.8%
Arthritis 0.9%
Constipation 0.9%
Diabetes Mellitus 0.9%
Hyperlipidaemia 0.9%
Motor Developmental Delay 16.7%
Paralysis 16.7%
Cellulitis 11.1%
Osteitis 11.1%
Pyrexia 11.1%
Angina Pectoris 5.6%
Hodgkin's Disease Stage Iii 5.6%
Hypotension 5.6%
Shock 5.6%
Urinary Incontinence 5.6%
Urticaria 5.6%
Concomitant
Prophylaxis 22.5%
Premedication 10.2%
Product Used For Unknown Indication 6.7%
Hypertension 6.6%
Breast Cancer 5.1%
Non-small Cell Lung Cancer 4.9%
Colitis Ulcerative 4.9%
Drug Use For Unknown Indication 4.2%
Constipation 3.6%
Prophylaxis Of Nausea And Vomiting 3.6%
Renal Cell Carcinoma 3.5%
Rheumatoid Arthritis 3.2%
Cancer Pain 3.0%
Lung Adenocarcinoma Metastatic 3.0%
Lung Neoplasm Malignant 2.8%
Prophylaxis Against Gastrointestinal Ulcer 2.7%
Pain 2.5%
Rectal Cancer 2.4%
Diabetes Mellitus 2.2%
Chronic Hepatitis C 2.2%
Neutrophil Count Decreased 9.0%
Osteitis 9.0%
Vomiting 7.0%
White Blood Cell Count Decreased 7.0%
Insomnia 6.5%
Sepsis 6.5%
Pneumonia 6.0%
Somnolence 6.0%
Renal Failure Acute 5.0%
Pyrexia 4.5%
Renal Cell Carcinoma 4.5%
C-reactive Protein Increased 3.5%
Hyperkalaemia 3.5%
Osteomyelitis 3.5%
Shock 3.5%
Stomatitis 3.5%
Anaphylactic Shock 3.0%
Cardiac Failure 3.0%
Disease Progression 3.0%
Hypoxia 3.0%

Drug Data